Noida, India

Satyanarayana Kallem

This inventor holds 1 USPTO granted patent. Top assignee: Medivation Technologies, Inc.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satyanarayana Kallem. Retrieved from https://idiyas.com/inventor/satyanarayana-kallem

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Satyanarayana Kallem

Introduction

Satyanarayana Kallem is a notable inventor based in Noida, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating various disorders. His work is characterized by a focus on innovative solutions to complex health issues.

Latest Patents

Kallem holds a patent for "Heterocyclic compounds and methods of use." This patent provides valuable compounds and outlines methods for using these compounds to treat metabolic disorders and hyperproliferative disorders. The patent emphasizes the administration of these compounds in conjunction with hormone receptor antagonists, showcasing Kallem's commitment to advancing therapeutic options.

Career Highlights

Kallem is associated with Medivation Technologies, Inc., where he applies his expertise in drug development and research. His work at the company reflects a dedication to improving health outcomes through innovative pharmaceutical solutions. With a patent portfolio that includes 1 patent, Kallem continues to contribute to the scientific community.

Collaborations

Kallem has collaborated with notable colleagues such as Brahmam Pujala and Ramniwas Jangir. These partnerships highlight the collaborative nature of research and innovation in the field of medicinal chemistry.

Conclusion

Satyanarayana Kallem's contributions to the field of medicinal chemistry through his innovative patents and collaborations underscore his role as a significant inventor. His work continues to pave the way for advancements in the treatment of metabolic and hyperproliferative disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…